These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2058080)

  • 1. [Prognosis and life expectancy in multiple sclerosis].
    Angstwurm H
    Versicherungsmedizin; 1991 Apr; 43(2):52-4. PubMed ID: 2058080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
    Skoog B; Runmarker B; Winblad S; Ekholm S; Andersen O
    Brain; 2012 Mar; 135(Pt 3):900-11. PubMed ID: 22366800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models.
    Riise T; Grønning M; Aarli JA; Nyland H; Larsen JP; Edland A
    J Clin Epidemiol; 1988; 41(10):1031-6. PubMed ID: 3193137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis in multiple sclerosis.
    Kurtzke JF; Beebe GW; Nagler B; Auth TL; Kurland LT; Nefzger MD
    Trans Am Neurol Assoc; 1973; 98():272-4. PubMed ID: 4784953
    [No Abstract]   [Full Text] [Related]  

  • 5. Life expectancy in patients attending multiple sclerosis clinics.
    Sadovnick AD; Ebers GC; Wilson RW; Paty DW
    Neurology; 1992 May; 42(5):991-4. PubMed ID: 1579256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multiple sclerosis as mortality diagnosis in the Federal Republic of Germany (author's transl)].
    Resch J
    Fortschr Neurol Psychiatr; 1982 Feb; 50(2):52-63. PubMed ID: 7095715
    [No Abstract]   [Full Text] [Related]  

  • 7. [Course of illness and prognosis of multiple sclerosis. 2: Predictive value of clinical and paraclinical factors].
    Flachenecker P; Hartung HP
    Nervenarzt; 1996 Jun; 67(6):444-51. PubMed ID: 8767198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality in multiple sclerosis: a review.
    Ragonese P; Aridon P; Salemi G; D'Amelio M; Savettieri G
    Eur J Neurol; 2008 Feb; 15(2):123-7. PubMed ID: 18217882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland.
    Phadke JG
    J Neurol Neurosurg Psychiatry; 1987 May; 50(5):523-31. PubMed ID: 3495637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability and mortality in a cohort of multiple sclerosis patients: a reappraisal.
    Bergamaschi R; Montomoli C; Candeloro E; Fratti C; Citterio A; Cosi V
    Neuroepidemiology; 2005; 25(1):15-8. PubMed ID: 15855800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival in multiple sclerosis.
    Poser S; Kurtzke JF; Poser W; Schlaf G
    J Clin Epidemiol; 1989; 42(2):159-68. PubMed ID: 2918325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life expectancy in Germany until 2050.
    Bomsdorf E
    Exp Gerontol; 2004 Feb; 39(2):159-63. PubMed ID: 15036408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history and treatment of multiple sclerosis.
    Weinshenker BG; Sibley WA
    Curr Opin Neurol Neurosurg; 1992 Apr; 5(2):203-11. PubMed ID: 1377973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiple sclerosis mortality in Poland].
    Cendrowski W
    Neurol Neurochir Pol; 1986; 20(5):444-7. PubMed ID: 3587514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognosis of multiple sclerosis in Australia.
    McLeod JG; Barnett MH; Macaskill P; Williams DB
    J Neurol Sci; 2007 May; 256(1-2):35-8. PubMed ID: 17368674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Course of illness and prognosis of multiple sclerosis. 1: The natural illness course].
    Flachenecker P; Hartung HP
    Nervenarzt; 1996 Jun; 67(6):435-43. PubMed ID: 8767197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in disability profile and quality of life in multiple sclerosis patients: a five-year longitudinal study using the Multiple Sclerosis Impact Profile (MSIP).
    Wynia K; van Wijlen AT; Middel B; Reijneveld SA; Meilof JF
    Mult Scler; 2012 May; 18(5):654-61. PubMed ID: 21965423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incorporation of work disability into the prolonged life expectancy process].
    Scholz RD; Neumann H; Schippan U
    Z Gesamte Hyg; 1989 Jun; 35(6):370-1. PubMed ID: 2800637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between onset age and disability in multiple sclerosis patients studied using MSSS and a progression model.
    Ramachandran S; Strange RC; Jones PW; Kalra S; Nayak D; Hawkins CP
    Mult Scler Relat Disord; 2014 Sep; 3(5):593-9. PubMed ID: 26265271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Better life expectations of SM patients: 21 years follow up of patients treated with interferon beta-1b].
    Komoly S
    Ideggyogy Sz; 2013 Mar; 66(3-4):143-4. PubMed ID: 23750430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.